The project is progressing. Perhaps 88c was overpriced? Or investors thought this would all happen in a whirlwind of rapid activity rather than in the carefully planned and systematic steps that all successful ventures advance. This is a stock for the patient which I have no doubt will be repaid. In 12 months this price will look incredibly cheap and we'll be kicking ourselves for not buying more.
